key: cord-0885185-lnbfb9p3 authors: Mirzaei, Fatemeh; Tavilani, Alireza; Asefy, Zahra; Abbasi, Ebrahim title: Prolactin and susceptibility to COVID-19 infection date: 2021-08-10 journal: Med Hypotheses DOI: 10.1016/j.mehy.2021.110662 sha: f5c18e07811a4c38e87e4cbd1d2c66fc9abd7f02 doc_id: 885185 cord_uid: lnbfb9p3 nan the author suggested that cigarette smokers, children, and pregnant women have due to higher prolactin level are at low risk for COVID-19. The prolactin levels after smoking is still debated. Various studies documented that prolactin secretion inhibits in chronic cigarette smokers [2] . Chronic exposure to nicotine inhibits prolactin secretion by activation of nicotinic receptors of the dopamine neurons, releasing dopamine as a prolactin-inhibitor factor. Moreover, nicotine can reduce prolactin gene expression in rat pituitary cell lines [3] . Hence, prolactin concentration is lower in chronic smokers compared with non-smokers. This may contribute to the decreased rate of fertility in chronic smokers. Furthermore, significant reductions in prolactin concentrations are found to happen in women who smoke during pregnancy and breast-feeding smokers [4] . However, some other studies reported that prolactin secretion increase after [5] . The low hospitalization rate in smoker COVID-19 patients might be due to the antithrombosis and anti-inflammatory effects of alpha particles and nicotine in the smoke [6] . Despite the protective effect of smoking against COVID-19, it is a significant risk factor for bacterial and viral infections [6] . It has been reported that smokers 2 times likely to develop pneumonia, and 5 times to develop influenza. Evidence showed that smoking is related to more severe disease, a greater risk of ICU admission, and more mortality in cases with COVID-19 admitted to hospital [7, 8] . Hopkinson el al., by review the symptom of more than 2.4 million people, showed that smokers had a higher COVID-19 symptom burden, and were more likely to need hospitalization compared with non-smokers [7] . The author referred to the Kopelman et al., study and showed low levels of blood prolactin in obese patients. However, this study reported the low levels of prolactin in obese nonresponders (patients without prolactin response to symptomatic hypoglycemia) [9] . Some studies showed that basal prolactin concentrations are similar in obese and normal-weight humans, whereas some others reported high levels [10] or low levels in obese [11] . However, chronic inflammation, impaired immune responses, change of gut microbiota, high ACE2 expression, insulin resistance, hyperglycemia, excess fat deposition, leptin resistance, and decreased adiponectin make obese patients susceptible to COVID-19 infection [12, 13] . Numerous molecular and physiological reasons have been reported for the low prevalence of COVID-19 among children and women [14, 15] . Although pregnant women have high levels of prolactin, they are more susceptible to COVID-19 compared to the general population. Other studies reported that pregnant women and non-pregnant have similar susceptibility for COVID-19 [16] . The authors declare no conflict of interest. Not required. Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol 2020;139:103122. Dear editor We have no conflict of interest to disclose. Best Regards Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus? Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications Nicotine acts directly on pituitary GH3 cells to inhibit prolactin promoter activity Smoking and hormones in health and endocrine disorders Venous plasma nicotine correlates of hormonal effects of tobacco smoking Why Do Some Reports Claim that the Number of COVID-19 Hospitalized Smokers is Smaller than Expected? Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis Physiopathology of prolactin secretion in obesity Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes? Obesity and COVID-19: what makes obese host so vulnerable? Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy COVID-19) in Children: Prevalence, Diagnosis, Clinical Symptoms, and Treatment Molecular mechanisms of sex bias differences in COVID-19 mortality No source of funding or sponsorship.